BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4756331)

  • 41. Molecular regulation of platelet-dependent thrombosis.
    Freedman JE
    Circulation; 2005 Oct; 112(17):2725-34. PubMed ID: 16246969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of immunotropic drugs on adrenocortical functions.
    Patkowski J; Gieldanowski J
    Acta Physiol Pol; 1973; 24(4):561-70. PubMed ID: 4741489
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of plasma expanders on the formation of platelet-rich agglutination thrombi.
    Poliwoda H
    Bibl Haematol; 1969; 33():466-71. PubMed ID: 5384014
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effects of 3-n-butylphthalide on thrombosis formation and platelet function in rats].
    Xu HL; Feng YP
    Yao Xue Xue Bao; 2001 May; 36(5):329-33. PubMed ID: 12584852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
    Goto S; Tamura N; Ishida H; Ruggeri ZM
    J Am Coll Cardiol; 2006 Jan; 47(1):155-62. PubMed ID: 16386680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Study of the thrombotic resistance of pyrolytic is a tropic graphite as a prospective material for artificial hear valve elements].
    Dobrova NB; Drogaĭtsev AD; Smurova EV; Zubkov EV
    Eksp Khir Anesteziol; 1974; (6):8-11. PubMed ID: 4461257
    [No Abstract]   [Full Text] [Related]  

  • 47. [Experimental arterial thrombosis. Effect of an alpha blocking agent: nicergoline].
    Der Agopian P; Rosa A; Gautier JC; Lhermitte F
    Nouv Presse Med; 1973 Oct; 2(38):2521-4. PubMed ID: 4148699
    [No Abstract]   [Full Text] [Related]  

  • 48. Prostaglandins and platelet aggregation in vivo. II. Influence of PGE1 and PGF1 alpha on platelet thrombus formation induced by an electric stimulus in veins on the rat brain surface.
    Kloeze J
    Thromb Diath Haemorrh; 1970 May; 23(2):293-8. PubMed ID: 5426211
    [No Abstract]   [Full Text] [Related]  

  • 49. The thrombogenicity of Dacron arterial grafts and its modification by platelet inhibitory drugs.
    Kester RC
    Ann R Coll Surg Engl; 1984 Jul; 66(4):241-6. PubMed ID: 6234841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Data on thrombophilic states].
    Raffaello B; Bruno B
    Haematol Lat; 1969; 12(3):569-94. PubMed ID: 4919424
    [No Abstract]   [Full Text] [Related]  

  • 51. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
    Hoylaerts MF
    Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of neferine and its combination with taurine on platelet aggregation and experimental thrombosis in rats].
    Huang HL; Rao MR
    Yao Xue Xue Bao; 1995; 30(7):486-90. PubMed ID: 7484155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi in rabbits.
    Hirsh J; Buchanan M; Glynn MF; Mustard JF
    J Lab Clin Med; 1968 Aug; 72(2):245-55. PubMed ID: 5671200
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of xanthine derivatives on thrombocyte aggregation and other hemostatic indices].
    Lakin KM; Ovnatanova MS; Matiashova MA; Mashkovskiĭ MD
    Biull Eksp Biol Med; 1980 Feb; 89(2):181-2. PubMed ID: 7370418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterisation of a novel series of aprotinin-derived anticoagulants. II. Comparative antithrombotic effects on primary thrombus formation in vivo.
    Stassen JM; Lambeir AM; Vreys I; Deckmyn H; Matthyssens G; Nyström A; Vermylen J
    Thromb Haemost; 1995 Aug; 74(2):655-9. PubMed ID: 8585002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Controlled study on the effect of a new substance in peripheral arterial diseases].
    Poti R; Megha A; Pini M; Bulletti G
    Minerva Cardioangiol; 1974; 22(7-8):574-87. PubMed ID: 4605589
    [No Abstract]   [Full Text] [Related]  

  • 58. Interference of bencyclan with 11-hydroxycorticosteroids determinations.
    Radó JP
    Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):186-8. PubMed ID: 1002354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bencyclan's effects "in vitro" on fibrinolysis (author's transl)].
    Bucci M; Faggiani L; Formichi R; Paoli L
    Quad Sclavo Diagn; 1977 Dec; 13(4):478-81. PubMed ID: 614608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Influence of bencyclan on regional cerebral blood flow in patients with insufficient cerebral blood flow (author's transl)].
    Herschaft H; Gleim F; Duus P
    Klin Wochenschr; 1974 May; 52(6):293-5. PubMed ID: 4409844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.